RE: What changed8 Feb 2026 10:40
@JK reference your cynical views below. I feel that some of it may be on point, even though I don’t want to believe it.
LAYMAN'S ATTEMP AT TRANSLATION OF TIM's COMMENTS IN NOVEMBERV2025 RNS>>
"The whole team is dedicated to securing a partnership deal that does justice [read> we've been badly lowballed] to the innovation and clinical potential of P140, valuing a more methodical approach over speed [read> we're reeling and are now playing for time], so the best outcome for shareholders [read> and for management, who hold very few shares] can be achieved. We are seeking a partner whose culture and aspirations match those of the Board [read> who gives us the highest retention package and perks], prioritising long-term synergy [read> upfront fees will be much smaller than seen in the market, so we are pivoting to royalties in many years' time. In the meantime, we can accrue more lucrative share options and max out potential rewards].
A best guess assessment only, DYOR